2006
DOI: 10.1016/j.vetpar.2006.02.024
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of buparvaquone (BUTA-Kel™ KELA, Belgium) as a treatment of East Coast fever in cattle, in the peri-urban of Dar Es Salaam city, Tanzania

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 6 publications
0
6
0
Order By: Relevance
“…However, a relatively low tick burden (<10 ticks /animal) was recorded in animals with a suspicion of ECF. Buparvaquone (Butalex®) and Parvaquone (Clexon®, Parvaxone®) were used to treat ECF cases (Dolan 1986;Mbwambo et al 2002Mbwambo et al , 2006. However, these drugs were expensive and not readily available in North Kivu.…”
Section: Introductionmentioning
confidence: 99%
“…However, a relatively low tick burden (<10 ticks /animal) was recorded in animals with a suspicion of ECF. Buparvaquone (Butalex®) and Parvaquone (Clexon®, Parvaxone®) were used to treat ECF cases (Dolan 1986;Mbwambo et al 2002Mbwambo et al , 2006. However, these drugs were expensive and not readily available in North Kivu.…”
Section: Introductionmentioning
confidence: 99%
“…in different ages of cattle, the use of buparvaquone in conjunction with oxytetracycline has been reported to achieve a treatment rate of over 90% (18). Another study found it to be effective at a rate of 95.2% (19). Successful treatment of Theileriosis in cattle and calves has been reported using buparvaquone, meloxicam, vitamins (A, E, D3, Biotin), and flumethrin applications (20).…”
Section: Usage Of Buparvaquonementioning
confidence: 99%
“…However, late stage treatment did eliminate the protozoal parasites from the blood and lymph nodes, it failed to improve the clinical condition of the affected animals, possibly due to irreversible damage to the lungs. Gharbi et al [35] reported that buparvaquone produces 86.66% clinical efficacy against Theileria annulata, but 97.1% and 95.2% efficacy against Theileria parva [36]. Bilgic et al [36] reported that the late treated cases failed to control by the drug buparvaquone due to the production of pulmonary edema.…”
Section: Therapeutic Aspectmentioning
confidence: 99%
“…Gharbi et al [35] reported that buparvaquone produces 86.66% clinical efficacy against Theileria annulata, but 97.1% and 95.2% efficacy against Theileria parva [36]. Bilgic et al [36] reported that the late treated cases failed to control by the drug buparvaquone due to the production of pulmonary edema.…”
Section: Therapeutic Aspectmentioning
confidence: 99%